Pharm/Biotech
Resources

Outsourcing Guide

Cont. Education

Software/Reports

Training Courses

Web Seminars

Jobs

Buyer's Guide

Home Page

Pharm Patents /
Licensing

Pharm News

Federal Register

Pharm Stocks

FDA Links

FDA Warning Letters

FDA Doc/cGMP

Pharm/Biotech Events

Consultants

Advertiser Info

Newsletter Subscription

Web Links

Suggestions

Site Map
 

 

 

 

Title:  Method for producing water dispersible sterol formulations

United States Patent:  6,054,144

Inventors:  Burruano; Brid (King of Prussia, PA); Bruce; Richard D. (Rydal, PA); Hoy; Michael R. (Sellersville, PA); Higgins, III; John D. (Ft. Washington, PA)

Assignee:  McNeil-PPC, Inc. (Skillman, NJ)

Appl. No.:  185788

Filed:  November 4, 1998

Abstract

A method for preparing .beta.-sitosterol, oryzanol, esters of both of these compounds and related compounds are disclosed which provides the sterol in a readily consumable form. The method includes the spray drying of the .beta.-sitosterol in a mixed micelle formulation. The product is provided in a convenient form that can be provided to food or drinks or incorporated into solid and suspension dosage forms.

DETAILED DESCRIPTION OF THE INVENTION

.beta.-sitosterols are typically derived from wood or agricultural sources, such as soy based mixtures. In addition to .beta.-sitosterol, as used throughout this application, .beta.-sitosterol is also understood to include the esters of .beta.-sitosterols, as well as stanol and stanol ester derivatives which are the reduced derivatives of the sterols. These derivatives are well known in the art and include patents U.S. Pat. No. 5,244,887; U.S. Pat. No. 5,502,045 and U.S. Pat. No. 5,698,527. The .beta.-sitosterols produced by the present invention are water dispersible. As used herein, water dispersible is understood to mean that when the .beta.-sitosterol spray dried formulation is placed in water, at least 200 mg formula/ml water will disperse with mild agitation. Those with skill in the art will appreciate that ordinarily .beta.-sitosterols are hydrophobic materials, and upon the addition of the .beta.-sitosterol to water, the .beta.-sitosterol will float on top of the water and will not become dispersed.

The present invention is also applicable to another class of cholesterol-lowering compounds, orynzanol and its esters. These materials are also known in the art as well as the esters of the oryzanol compound, see for example, U.S. Pat. No. 5,514,398, the contents hereby incorporated by reference and PCT WO 98/01519 published Jan. 15, 1998. The present invention also provides the oryzanol, esters of oryzanol and other related compounds in a more dispersible form. Although the remaining specification will refer to .beta.-sitosterols, the present invention is equally applicable to said oryzanol and related compounds.

In order to be most effective when ingested, the particle size of the .beta.-sitosterol should be in the range of from 10 to 40 microns. More preferably the particle size should from about 20 to 35 microns. Any grinding technique known in the art may be used to grind the .beta.-sitosterol. Suitable methods include pulverizing, rotary hammermill, air milling and the like of which air milling is most preferred. Smaller particles sizes are preferred in that the resulting .beta.-sitosterol product is more readily exposed to bile salts in the digestive tract. The handling properties of the smaller particle size product are less desirable, resulting in higher angle of rupture, higher angle of repose and compressibility. The handling of the water-dispersible .beta.-sitosterol product can be improved with increased particle size; however, this is believed to be detrimental to the efficacy of the .beta.-sitosterol in reducing serum cholesterol.

In order to form the water dispersible .beta.-sitosterols appropriate surfactants are required. The present invention employs a dual surfactant system. One surfactant in the system is monofunctional, while the second surfactant is polyfunctional. The monofunctional surfactants tend to be more hydrophobic, whereas the polyfunctional surfactants tend to be hydrophilic. The two-surfactant system employed in this invention creates a mixed micelle system that results in the water-dispersible product. As used herein monofunctional is defined as the ability of the surfactant to bond to the .beta.-sitosterol. The polyfunctional surfactant has the ability to bond to the .beta.-sitosterol as well as to the other surfactant.

Useful surfactants in the practice of the present invention include polyglycerol esters, polysorbates, mono and diglycerides of fatty acids, propylene glycol esters, sucrose fatty acid esters and polyoxyethylene derivatives of sorbitan fatty acid esters. These surfactants are well known in the art and are commercially available.

Suitable polyglycerol esters include triglyceryl monostearate, hexaglyceryl distearate, hexaglyceryl monopalimate, hexaglyceryl dipalmitate, decaglyceryl distearate, decaglyceryl monoleate, decaglyceryl dioleate, decaglycerol monopalmitate, decaglycerol dipalmitate, decaglyceryl monostearate, octaglycerol monoleate, octaglycerol monostearate and decaglycerol monocaprylate.

Other useful surfactants include polysorbates made from the reaction product of monoglycerides or sorbitan esters with ethylene oxides. Examples of useful polysorbates include polyoxyethylene 20 mono- and diglycerides of saturated fatty acids, polyoxyethylene 4 sorbitan monostearate, polyoxyethylene 20 sorbitan tristearate, polyoxyethylene 20 sorbitan monooleate, polyoxyethylene 5 sorbitan monooleate, polyoxyethylene 20, sorbitan trioleate, sorbitan monopalmitate, sorbitan monolaurate, propylene glycol monolaurate, glycerol monostearate, diglycerol monostearate, glycerol lactyl-palmitate.

Other suitable surfactants include, with HLB values provided in brackets, [ ], include decaglycerol monolaurate [15.5]; decaglycerol distearate [10.5]; decaglycerol dioleate [10.5]; decaglycerol dipalmitate [11.0]; decaglycerol monostearate [13.0]; decaglycerol monooleate [13.5]; hexaglycerol monostearate [12.0]; hexaglycerol monooleate [10.5]; hexaglycerol monoshortening [12.0]; polyoxyethylene (20) sorbitan monolaurate [16.7]; polyoxyethylene (4) sorbitan monolaurate [13.3]; polyoxyethylene (20) sorbitan monopalmitate [15.6]; polyoxyethylene (20) sorbitan monostearate [14.9]; polyoxyethylene (20) sorbitan tristearate [10.5]; polyoxyethylene (20) sorbitan monooleate [15.0]; polyoxyethylene (5) sorbitan monooleate [10.0]; polyoxyethylene (20) sorbitan trioleate [11.0]. As is appreciated by those with skill in the art, the HLB value for a surfactant is an expression of its Hydrophile-Lipophile balance, i.e., the balance of the size and strength of the hydrophilic (polar) and lipophilic (non-polar) groups of the surfactant.

Lactic acid derivatives include sodium stearoyl lactylate and calcium stearoyl lactylate.

The level of monofunctional surfactant is typically from about 1 to about 10 weight percent based upon the final dried weight of the .beta.-sitosterol product, preferably from about 1.5 to about 4, and most preferably about 2.0 to about 2.5 weight percent. The level of polyfunctional surfactant is typically from about 0.5 to about 10 weight percent based upon the final dried weight of the .beta.-sitosterol product, preferably from about 2 to about 4, and most preferably about 2.0 to about 2.5 weight percent. TWEEN 40 is the preferred monfunctional surfactant and SPAN 80 is the preferred polyfunctional surfactant. Suitable ratios of mofunctional/polyfunctional surfactants which form the mixed micelle include from about 1:6 to about 1.5:1, preferably from about 1:4 to about 1.3:1, most preferably about 1:1 ratio. The level of surfactant employed ranges from about 0.5 to about 8 percent by weight total surfactant system, preferably 1 to about 6, most preferably from about 3 to about 4 percent by weight.

In a preferred embodiment, in addition to the surfactant, other excipients, tableting aids etc. are added to the formulation as the suspension is formed, prior to the spray drying process. This conveniently incorporates tableting aids and other necessary ingredients thereby eliminating or reducing unit-manufacturing steps. If desired, ingredients can also be added to the .beta.-sitosterol after spray drying.

For example, lubricants, glidants, carriers, sweeteners, disintegrants, preservatives and other ingredients may be added to the suspension in the amount of from about 5 to about 40 weight percent, typically from about 10 to about 30 percent and most preferably to about 20 to about 25 percent. Suitable ingredients include binders are acacia mucilage, starch mucilage pregelatinised starch, sodium alignate, hydroxypropylmethyl cellulose (HPMC), starch paste, polyvinylpyrrolidone, carboxymethylcellulose, dextrin, ethyl cellulose, polyethylene glycol, guar gum, zein, hydroxyethyl cellulose, hydroxypropyl cellulose, methyl cellulose, polymethacrylates, and carboxymethylcellulose.

Disintegrating agents include microcystalline cellulose (e.g. Avicel R), sodium carboxymethyl cellulose (e.g. Nymcel R), modified cellulose gum (e.g. Ac-Di-Sol R), crosslinked providone, alginic acid and alginates, pregelatinised starch, sodium starch glycollate (e.g. Explotab R, Primojel R), modified corn starch (e.g. starch 1500R), starch (e.g. potato/maize starch), and ion exchange resin such as polacrin potassium (e.g. Amberlite IRP-88).

Examples of water-soluble fillers are: soluble lactose, compressible sugar, confectioners sugar, dextrose, mannitol, sodium chloride, sorbitol, xylitol. Examples of water-insoluble fillers are: calcium carbonate, magnesium carbonate, calcium phosphate (e.g. di and tri basic calcium phosphate), calcium sulphate, kaolin, microcystalline cellulose, powdered cellulose, pregelatinized starch, barium sulphate, magnesium trisilcate, aluminum hydroxide.

Generally lubricants are used in as low an amount as possible. Examples of lubricants include: stearates (e.g. magnesium or calcium stearate), talc, polyethylene glycol, liquid paraffin, sodium lauryl sulphate, magnesium lauryl sulphate, colloidal silicone dioxide, palmitostearate, stearic acid, zinc stearate, hydrogenated vegetable oil.

Glidants including talc, starch, magnesium stearate, silica derivatives, such as colloidal silica (e.g. AEROSIL) pyrogenic silica, hydrated sodium silicoaluminate, colloidal silicon dioxide.

Flavoring agents including orange, cherry, and strawberry, raspberry, grape and passion fruit.

Sweetening agents, include for example, sodium saccharin, aspartame, confectioners sugar, sorbitol, xylitol and mixtures thereof.

The .beta.-sitosterol and the other ingredients in the suspension should be uniformly mixed. Preferably the suspension is mixed by agitation, preferably through the use of a high-speed mixer. The particle size of the micelles in the suspension formed are from about 50 to about 400 microns, preferably from about 100 to about 300 microns and most preferably from about 150 to about 250 microns in size. The size of the micelles formed in the suspension may be measured through the use of a Turbimeter. The greater turbidity, the larger the micelle formation. It is expected that greater turbidty, i.e., larger micelles provides a more effective form of the .beta.-sitosterol for reducing cholesterol when consumed. Preferred turbidity levels are greater than about 2000, preferably greater than 2500 and most preferably greater than 3000 Nepthialic Turbidity Units (NTU). As used herein turbidity is understood to be the same as defined by the United States Pharmacopeia, the light scattering effect of suspended particles and turbidity as the measure of the decrease in the incident beam intensity per unit length of a given suspension. The range of turbidty values is from 0 to 20,000 NTU. As a point of reference the turbidity of water is zero. The turbidity of the samples was measured at room temperature.

After the suspension with the proper particle size is formed the suspension is dried. Suitable drying methods include freeze drying, rotary, vacuum and spray drying, of which spray drying is preferred. The final moisture content of the dried .beta.-sitosterol is preferably less than 1% by weight water. Lower moisture content generally provides improved flow characteristics.

When spray drying the suspension, it is preferable that the inlet temperature is from about 100 to 120oC., preferably from about 105 to about 115oC. and most preferably from 107 to about 112oC. The outlet temperature of the spray dryer is between about 65 and 85oC. and most preferably from about 73 to about 80oC.

The spray dried water-dispersible .beta.-sitosterol product is then recovered. The resulting water-dispersible .beta.-sitosterol is comprised of from greater than 50 percent by weight sterol, greater than 4 and preferable from about 5 to about 10 weight percent surfactant. In a highly preferred embodiment the .beta.-sitosterol also includes about 5 percent starch and about 5 percent silicon dioxide.

After the .beta.-sitosterol is removed from the dryer it is packaged in any suitable size as may be required. The form in which the .beta.-sitosterol is consumed varies depending on the preference of the consumer. Suitable forms include tablets, chewable dosages, in the preparation of food and beverages as well as applied to prepared beverages and foodstuffs. In a preferred embodiment, the .beta.-sitosterol may be packaged in single serving size packets containing from about 5 to about 50 grams per packet.

The present invention provides advantages over previous disclosures that provide water-dispersible .beta.-sitosterols in that several costly and time consuming process steps are eliminated. Prior disclosures required both a homogenization and deaeration step in order to produce the water-dispersible .beta.-sitosterol. The present invention provides the water-dispersible .beta.-sitosterol through the use of the selection of advantageous combinations of surfactants. The invention will now be illustrated by, but is not intended to be limited to, the following examples. In the examples the starch was ground to a particle size of approximately 10 microns. In these examples it is understood that unless noted otherwise, all parts are weight percent. The following raw materials are available from the following suppliers.

CAB O SIL colloidal silicon dioxide, Degussa Corp.

AEROSIL A200 colloidal silicon dioxide, Cabot Corp.

EM Compress dibasic calcium phosphate dihydrate, Edward Mendall Compress Co., Inc.

M100 maltrodextrin (dextrose equivalent of about 10) Grain Process Corp.

Pluronic L-44 a polyethylene-propylene glycol copolymer, BASF Corp.

SPAN 80 sorbitan monooleate, ICI Americas, Inc.

Starch: Starch NF-, National Starch and Chemicals Inc.

Sterols: Generol 122N available from Henkel Company, Ambler, Pa.

TWEEN 40 polyoxyethylene 20 sorbitan monopalmitate, ICI Americas Inc.

TWEEN 60 polyoxyethylene 20 sorbitan monostearate, ICI Americas Inc.

Claim 1 of 12 Claims

1. A process for preparing water-dispersible oryzanol comprising:

a) providing an aqueous stream;

b) admixing to the aqueous stream of from about 2 to 2.5 weight percent of a monofunctional surfactant and of from about 2.25 weight percent of a polyfunctional surfactant to form a water surfactant mixture;

c) admixing oryzanol to the water surfactant mixture to form a oryzanol suspension;

d) drying the oryzanol suspension to recover a water-dispersible oryzanol;

wherein the above process is performed in the absence of deaeration and homogenization steps.

 

____________________________________________
If you want to learn more about this patent, please go directly to the U.S. Patent and Trademark Office Web site to access the full patent.

 

 

[ Outsourcing Guide ] [ Cont. Education ] [ Software/Reports ] [ Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ]

[ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ]
[ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ]
[ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ]
[ Site Map ]